Back
NeuroBo Pharmaceuticals 10K Form
Sell
20
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.30
Seasonality Move:
-8.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NRBO News And Ratings
See the #1 stock for the next 7 days that we like better than NRBO
NRBO Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-5.59M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.50 |
| Price / Book: | 1.59 |
Profitability
| EPS (TTM): | -4.77000 |
|---|---|
| Net Income (TTM): | $-27.73M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
NeuroBo Pharmaceuticals Earnings Forecast
Key NeuroBo Pharmaceuticals Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 5 years.
NeuroBo Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NRBO |
| CUSIP: | 64132R |
| Website: | neurobopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NRBO Technical Analysis vs Fundamental Analysis
Sell
20
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy or a Sell?
-
NeuroBo Pharmaceuticals stock is rated a Sell
The current NeuroBo Pharmaceuticals [NRBO] share price is $2.39. The Score for NRBO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.